Cantai Therapeutics Email Formats
Biotechnology Research • 
United States • 1-10 Employees
Key Contact at Cantai Therapeutics
Keith Bahjat
Senior Vice President, Head of Research
Company overview
| Headquarters | United States |
| Website | |
| NAICS | 541714 |
| Founded | 2023 |
| Employees | 1-10 |
| Socials |
About Cantai Therapeutics
Transforming patient care in autoimmune disease by developing rationally designed bispecific antibodies that more effectively combine clinically validated mechanisms
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Vice President
Funding Data
Cantai Therapeutics has never raised funding before.
Italy
Australia
France
United Kingdom
Frequently asked questions
Cantai Therapeutics is located in US.
Cantai Therapeutics was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.
Cantai Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
